MaxCyte, Inc. financial statements
MaxCyte, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 33.03M | 10-K |
| Net income | −USD 44.63M | 10-K |
| Cash and equivalents | USD 20.07M | 10-Q |
| Total debt | USD 17.94M | EODHD |